Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /600062

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062

• SSE: 600062 • Delayed

17.85CNY -0.6%

2.64 USD

As of 6 June 2026, China Resources Double-Crane Pharmaceutical Co.,Ltd. has a market cap of $2.74B USD, ranking #5790 globally and #1286 in China. It ranks #456 in the Healthcare sector, and #13 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

5790

Country Rank

1286

Sector Rank

456

Industry Rank

Key Stats

Market Cap

$2.74BUSD

18.55B CNY

Enterprise Value

$2.66BUSD

18.05B CNY

Revenue (TTM)

$1.58BUSD

10.73B CNY

EBITDA (TTM)

$355.12MUSD

2.41B CNY

Net Income (TTM)

$240.07MUSD

1.63B CNY

EBITDA Margin

22%

Profit Margin

15%

PE Ratio

11.5

Forward PE

10.6

PS Ratio

1.7

PB Ratio

1.4

EV/EBITDA

7.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Qian Zhao open_in_new

Employees

13,184

Founded

1939

Website

dcpc.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.6%	-1.1%	-3.5%	-5.8%	-7%	-2.4%	-5.1%	-14%	50%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600062 华润双鹤药业股份有限公司 Class A ISIN: CNE000000Q94 Shares Out.: Shares Outstanding: 1.026B¹ Shares Float: 398.951M² TV: TradingView: SSE: 600062 SA: Stock Analysis: SHA: 600062 YF: Yahoo Finance: 600062.SS GF: Google Finance: SHA: 600062 BA: Barron's: 600062 MS: Morningstar: XSHG: 600062	17.85 CNY	TV: TradingView: SSE: 600062 SA: Stock Analysis: SHA: 600062 YF: Yahoo Finance: 600062.SS GF: Google Finance: SHA: 600062 BA: Barron's: 600062 MS: Morningstar: XSHG: 600062

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About China Resources Double-Crane Pharmaceutical Co.,Ltd.

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 479%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 232%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 90%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.21B 28.47B CNY 53%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY 19%	8.1	China
Byhealth Co., Ltd. SHE: 300146	$2.61B 17.67B CNY -4.7%	24.0	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 1K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 979%	-	United States
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 306%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 301%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 221%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 208%	23.1	India

chevron_leftBack